Cadrenal Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CVKD and other ETFs, options, and stocks.About CVKD
Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.
CEOQuang X. Pham
CEOQuang X. Pham
Employees4
Employees4
HeadquartersPonte Vedra Beach, Florida
HeadquartersPonte Vedra Beach, Florida
Founded2022
Founded2022
Employees4
Employees4
CVKD Key Statistics
Market cap28.89M
Market cap28.89M
Price-Earnings ratio-1.60
Price-Earnings ratio-1.60
Dividend yield—
Dividend yield—
Average volume29.04K
Average volume29.04K
High today$14.95
High today$14.95
Low today$13.10
Low today$13.10
Open price$13.19
Open price$13.19
Volume44.72K
Volume44.72K
52 Week high$22.90
52 Week high$22.90
52 Week low$5.70
52 Week low$5.70
People also own
Based on the portfolios of people who own CVKD. This list is generated using Robinhood data, and it’s not a recommendation.